IBO:CC - Universal Ibogaine Announces Results of Annual General Meeting
(TheNewswire)
Calgary, AB – TheNewswire - October 5, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the“ Company ”), a life sciences company with a mission to delivermedicalized ibogaine-centered addiction care, is pleased to announcethat all resolutions were passed by the requisite majority ofshareholders at its annual general meeting (“ AGM ”) which washeld on October 3, 2022 in Vancouver, BC.
UI’s five incumbent directors, Ian Campbell, AnthonyDeCristofaro, Nicholas Karos, Dr. Alberto Sola Agullo, and RobertTurner were re-elected by shareholders to the Company’s Board ofDirectors. The shareholders also approved the re-appointment ofDeloitte LLP as auditors of the Company for the ensuing year, andapproved the Company’s 2021 Stock Option Plan, the Company’s 2022Equity Incentive Compensation Plan (the “ EICP ”) and theCompany’s 2022 Stock Option Plan (the “ 2022 SOP ”).
As disclosed in the Company’s August 25, 2022Management Information Circular for the AGM (the “ Info. Circular ”),shareholders were requested to approve replacing the former 2021 StockOption Plan (which had a 20% fixed cap) with the new EICP (which willhave a 10% fixed cap) and the new 2022 SOP (which will have a 10%floating cap). The terms of the EICP and the 2022 SOP are alsosubject to approval by the TSX Venture Exchange. A copy of each ofthe Company’s 2021 Stock Option Plan, the EICP and the 2022 SOP areincluded in the Info. Circular, which is available for review underthe Company’s profile on SEDAR at www.sedar.com .
About UniversalIbogaine Inc.
UI is a life sciences company, with a mission totransform addiction treatment using medicalized ibogaine through aplanned Canadian clinical trial focused on opioid use disorder, andultimately to utilize that protocol globally through planned futurelicensing agreements. UIis concurrently developing a state of the art holistic addictiontreatment protocol at its Kelburn Recovery Centre that, which whenpaired with the planned ibogaine detox protocol, is intended torevolutionize the way we treat addiction and drastically improve thelives of individuals and families affected byaddiction.
NEITHER THE TSXVENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM ISDEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTSRESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THISRELEASE.
CAUTIONARY STATEMENTREGARDING FORWARD-LOOKING STATEMENTS
?This news release may containforward-looking statements and information. Forward-lookinginformation is frequently characterized by words such ?as"plans", "expect", "project","intend", "will", "believe","anticipate", "estimate", "scheduled",??"potential", or other similar words, or statementsthat certain events or conditions "may", "should"or ??"could" occur. The forward-looking statements andinformation are based on certain key expectations ?and assumptionsmade by UI. Although UI believes that the expectations andassumptions on which the forward-?looking statements are based arereasonable, undue reliance should not be placed on theforward-?looking statements because UI can give no assurance thatthey will prove to be correct.
Since ?forward-looking statementsaddress future events and conditions, by their very nature theyinvolve ?inherent risks and uncertainties. Actual results coulddiffer materially from those currently anticipated ?due to a numberof factors and risks, which include, but are not limited to, risksthat required ?regulatory approvals are not obtained. The reader iscautioned that assumptions used in the ?preparation of suchinformation, although considered reasonable by UI at the time of?preparation, may prove to be incorrect and readers are cautionednot to place undue reliance on ?forward-looking information, whichspeaks only to conditions as of the date hereof. UI does not?undertake any obligation to release publicly any revisions toforward-looking information contained ?herein to reflect events orcircumstances that occur after the date hereof or to reflect theoccurrence ?of unanticipated events, except as may be required underapplicable securities laws. ?
For furtherinformation:
InvestorRelations: Dugan Selkirk,IR Manager
dugan.selkirk@universalibogaine.com
Related Links
Copyright (c) 2022 TheNewswire - All rights reserved.